Intravitreal bevacizumab for delayed radiation maculopathy and papillopathy after irradiation for maxillary sinus cancer

BACKGROUND: The evaluation of intravitreal bevacizumab treatment for delayed radiation maculopathy and papillopathy after irradiation for maxillary sinus cancer. CASE REPORT: A patient with radiation maculopathy and papillopathy was treated with intravitreal bevacizumab (1.25 mg). Main outcome measu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gondo, Miki, Sakai, Tsutomu, Tsuneoka, Hiroshi, Kanehira, Chihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180486/
https://www.ncbi.nlm.nih.gov/pubmed/21966189
http://dx.doi.org/10.2147/OPTH.S23650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180486/
https://www.ncbi.nlm.nih.gov/pubmed/21966189
http://dx.doi.org/10.2147/OPTH.S23650

Ejemplares similares